Victory Capital Management Inc Adc Therapeutics Sa Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 04, 2021
SELL
$22.75 - $34.05 $395,372 - $591,754
-17,379 Closed
0 $0
Q4 2020

Feb 01, 2021
SELL
$25.26 - $38.02 $31,372 - $47,220
-1,242 Reduced 6.67%
17,379 $556,000
Q3 2020

Nov 09, 2020
SELL
$32.87 - $51.05 $260,264 - $404,213
-7,918 Reduced 29.84%
18,621 $614,000
Q2 2020

Aug 07, 2020
BUY
$29.65 - $46.81 $786,881 - $1.24 Million
26,539 New
26,539 $1.24 Million

Others Institutions Holding ADCT

# of Institutions
79
Shares Held
55M
Call Options Held
82.7K
Put Options Held
31.5K
View Full List

About ADC Therapeutics SA

ADCT Quotes by TradingView
  • Ticker ADCT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,645,296
  • Market Cap $155M
  • Description
  • ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...
More about ADCT
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email